TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
ZYBT

Zhengye Biotechnology Holding Limited

Healthcare · Drug Manufacturers - Specialty & Generic

1.20$ -4.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement ZYBT
Line item Q3 25 Q1 26
100.0% 100.0%
91.7% 91.7%
8.3% 8.3%
16.7% 16.7%
30.3% –
85.3% 85.3%
-77.0% -77.0%
3.0% 3.0%
-75.8% -75.8%
30.4% 30.4%
-89.0% -89.0%
-51.8% -51.7%

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?